Stipe Therapeutics Is A Biotechnology Company Based In Aarhusdenmarkfounded In 2018 As A Spin Out From Aarhus Universityae S Department Of Biomedicinethe Company Specializes In Immune Oncologyfocusing On Developing Therapies That Target The Stimulator Of Interferon Genesstingpathway To Enhance Immune Responses Against Cancer With A Team Of Approximately 26 Employeesstipe Therapeutics Has Secured A 20 Million In Series A Financing To Support Its Drug Development Effortsthe Company Is Advancing First In Class Synthetic Peptides That Aim To Sensitize The Tumor Microenvironment While Minimizing Inflammatory Side Effectsits Proprietary Platform Enhances Sting Pathway Activation To Promote Tumor Growth Inhibition And Immune Memorykey Leadership Includes Co Founder And Ceo Claus Olesenchairman Christian Schetterand Chief Development Officer Richard Bethell
